Thomas Büch

1.7k total citations
31 papers, 1.4k citations indexed

About

Thomas Büch is a scholar working on Molecular Biology, Oncology and Nutrition and Dietetics. According to data from OpenAlex, Thomas Büch has authored 31 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Nutrition and Dietetics. Recurrent topics in Thomas Büch's work include Histone Deacetylase Inhibitors Research (7 papers), Biochemical Analysis and Sensing Techniques (5 papers) and Ion Channels and Receptors (4 papers). Thomas Büch is often cited by papers focused on Histone Deacetylase Inhibitors Research (7 papers), Biochemical Analysis and Sensing Techniques (5 papers) and Ion Channels and Receptors (4 papers). Thomas Büch collaborates with scholars based in Germany, United States and Poland. Thomas Büch's co-authors include Ernst Malle, Hermann-Josef Gröne, Thomas Gudermann, Achim Aigner, Andreas Breit, Finn K. Hansen, Ellen Damm, Nina Reßing, Ingrid Boekhoff and Hermann Kalwa and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Cancer.

In The Last Decade

Thomas Büch

29 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Büch Germany 18 661 174 171 168 152 31 1.4k
Xu Cao China 22 572 0.9× 46 0.3× 100 0.6× 319 1.9× 195 1.3× 53 1.7k
Doina Popov Romania 25 785 1.2× 137 0.8× 102 0.6× 240 1.4× 103 0.7× 65 2.1k
Takako Hishiki Japan 30 1.4k 2.1× 64 0.4× 139 0.8× 122 0.7× 165 1.1× 57 2.4k
Zhizhong Xie China 17 652 1.0× 40 0.2× 98 0.6× 120 0.7× 60 0.4× 55 1.4k
Cai Li China 18 475 0.7× 100 0.6× 138 0.8× 80 0.5× 386 2.5× 61 1.4k
Anastasia Pyriochou Greece 18 570 0.9× 61 0.4× 225 1.3× 178 1.1× 89 0.6× 22 1.8k
Kang Cheng United States 26 881 1.3× 92 0.5× 107 0.6× 57 0.3× 67 0.4× 70 1.9k
Joseph R. Burgoyne United Kingdom 26 1.5k 2.2× 98 0.6× 75 0.4× 241 1.4× 84 0.6× 45 2.5k
Abu B. Al‐Mehdi United States 28 957 1.4× 79 0.5× 149 0.9× 405 2.4× 319 2.1× 37 2.7k
Rosemarie Marchan Germany 22 795 1.2× 110 0.6× 113 0.7× 180 1.1× 441 2.9× 50 1.7k

Countries citing papers authored by Thomas Büch

Since Specialization
Citations

This map shows the geographic impact of Thomas Büch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Büch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Büch more than expected).

Fields of papers citing papers by Thomas Büch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Büch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Büch. The network helps show where Thomas Büch may publish in the future.

Co-authorship network of co-authors of Thomas Büch

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Büch. A scholar is included among the top collaborators of Thomas Büch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Büch. Thomas Büch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Schäker‐Hübner, Linda, et al.. (2024). HDAC inhibitors activate lipid peroxidation and ferroptosis in gastric cancer. Biochemical Pharmacology. 225. 116257–116257. 18 indexed citations
5.
Lyros, Orestis, Stefan Niebisch, Matthias Mehdorn, et al.. (2021). Nrf2/Keap1-Pathway Activation and Reduced Susceptibility to Chemotherapy Treatment by Acidification in Esophageal Adenocarcinoma Cells. Cancers. 13(11). 2806–2806. 7 indexed citations
6.
Thieme, René, Thomas Büch, Anja Reinert, et al.. (2021). Tyrosine-modified linear PEIs for highly efficacious and biocompatible siRNA delivery in vitro and in vivo. Nanomedicine Nanotechnology Biology and Medicine. 36. 102403–102403. 29 indexed citations
7.
Büch, Thomas, Nicole Urban, Ulrike Weirauch, et al.. (2020). Restoration of MARCK enhances chemosensitivity in cancer. Journal of Cancer Research and Clinical Oncology. 146(4). 843–858. 12 indexed citations
8.
Ewe, Alexander, Thomas Büch, Anastasia Malek, et al.. (2019). Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA delivery in vitro and in vivo. Journal of Controlled Release. 319. 63–76. 113 indexed citations
9.
Büch, Thomas, Marius Grzelinski, Olaf Pinkenburg, Thomas Gudermann, & Achim Aigner. (2014). Cell-type specific and non-redundant anti-proliferative effects of shRNA-mediated Galpha12- and Galpha13 knockdown in lung cancer cell lines. Advances in Bioscience and Biotechnology. 5(1). 73–80. 1 indexed citations
10.
Büch, Thomas, Ingrid Boekhoff, Horst Thiermann, et al.. (2013). Functional expression of the transient receptor potential channel TRPA1, a sensor for toxic lung inhalants, in pulmonary epithelial cells. Chemico-Biological Interactions. 206(3). 462–471. 59 indexed citations
11.
Büch, Thomas, et al.. (2013). Chemosensory TRP Channels in the Respiratory Tract: Role in Toxic Lung Injury and Potential as “Sweet Spots” for Targeted Therapies. Reviews of physiology, biochemistry and pharmacology. 165. 31–65. 23 indexed citations
12.
Biebermann, Heike, et al.. (2013). TSH induces metallothionein 1 in thyrocytes via Gq/11- and PKC-dependent signaling. Journal of Molecular Endocrinology. 51(1). 79–90. 9 indexed citations
13.
Grzelinski, Marius, Olaf Pinkenburg, Thomas Büch, et al.. (2010). Critical Role of Gα12 and Gα13 for Human Small Cell Lung Cancer Cell Proliferation In vitro and Tumor Growth In vivo. Clinical Cancer Research. 16(5). 1402–1415. 31 indexed citations
14.
Breit, Andreas, Thomas Büch, Ingrid Boekhoff, et al.. (2010). Alternative G protein coupling and biased agonism: New insights into melanocortin-4 receptor signalling. Molecular and Cellular Endocrinology. 331(2). 232–240. 56 indexed citations
15.
Büch, Thomas, et al.. (2009). Pertussis Toxin-sensitive Signaling of Melanocortin-4 Receptors in Hypothalamic GT1-7 Cells Defines Agouti-related Protein as a Biased Agonist. Journal of Biological Chemistry. 284(39). 26411–26420. 91 indexed citations
16.
Büch, Thomas, Heike Biebermann, Hermann Kalwa, et al.. (2008). G13-dependent Activation of MAPK by Thyrotropin. Journal of Biological Chemistry. 283(29). 20330–20341. 31 indexed citations
17.
Breit, Andreas, Katharina Wolff, Hermann Kalwa, et al.. (2006). The Natural Inverse Agonist Agouti-related Protein Induces Arrestin-mediated Endocytosis of Melanocortin-3 and -4 Receptors. Journal of Biological Chemistry. 281(49). 37447–37456. 67 indexed citations
18.
Hackstein, Nils, Thomas Büch, Wigbert S. Rau, Rolf Weimer, & R. Klett. (2006). Split renal function measured by triphasic helical CT. European Journal of Radiology. 61(2). 303–309. 29 indexed citations
19.
Malle, Ernst, Thomas Büch, & Hermann-Josef Gröne. (2003). Myeloperoxidase in kidney disease. Kidney International. 64(6). 1956–1967. 301 indexed citations
20.
Büch, Thomas, et al.. (2000). Steroid hormone receptors and long term survival in invasive ovarian cancer. Cancer. 89(8). 1783–1791. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026